Refine by MP, party, committee, province, or result type.

Results 1-9 of 9
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  It is correct that if the use increases to very high levels, then it may produce much more harm, but we are far from the rates of prevalence of tobacco and alcohol.

May 8th, 2014Committee meeting

Dr. Bernard Le Foll

Health committee  Yes. I would think the analogy with tobacco may be better, but because of the damage caused it is probably in the same type of order. Yes. I agree. If you add widespread use, the damage will be higher compared to what we see right now.

May 8th, 2014Committee meeting

Dr. Bernard Le Foll

Health committee  To whom are you addressing the question?

May 8th, 2014Committee meeting

Dr. Bernard Le Foll

Health committee  Yes. I can comment on this. For the pharmaceuticals the situation is clear, because there are expert groups like the FDA or Health Canada that will evaluate the benefits risk. It is also true that these risks, when it's done, when the product comes to the market, may evolve with

May 8th, 2014Committee meeting

Dr. Bernard Le Foll

Health committee  Yes, nicotine overdose happens. This is becoming more frequent now that people can get access to nicotine in liquid form, such as in electronic cigarettes.

May 8th, 2014Committee meeting

Dr. Bernard Le Foll

Health committee  No, it would not happen, because the reality is that the only way you can get an overdose from a cigarette would be if you boiled the cigarette and then drank the contents. When you inhale, before getting an overdose, you would have so many side effects you would stop inhaling it

May 8th, 2014Committee meeting

Dr. Bernard Le Foll

Health committee  I can try to answer this question. I think one principle is that the more widely the drug is used, the more the impact on society. You have a different rate of impact based on the type of drug. Some drugs will create a more pronounced impact on mortality itself, some others will

May 8th, 2014Committee meeting

Dr. Bernard Le Foll

Health committee  Yes, thank you.

May 8th, 2014Committee meeting

Dr. Bernard Le Foll

Health committee  Thank you, Mr. Chair and committee members, for the invitation to speak to the standing committee. First, I will start with some information on my background. I am a clinician scientist working primarily on drug addiction. I am trained as an addiction physician, and my focus is

May 8th, 2014Committee meeting

Dr. Bernard Le Foll